Noel G Carlson

Dr. Noel G Carlson


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2012 in Expert Opinion on Medical Diagnostics
Verified
Journal Article
Closed access
AFAnette Simble Fjeldstad
Anette Simble Fjeldstad
NCNoel G Carlson
Noel G Carlson
JRJohn W Rose
John W Rose
Introduction: Multiple sclerosis (MS) is a disease of the central nervous system (CNS) that leads to axonal dysfunction and neuronal loss and often presents optic neuritis (ON). Decreased thickness of the retinal nerve fiber layer (RNFL) is a classic finding on ophthalmoscopic examination of patients with MS and especially noted in those patients with a history of ON. The thickness of the RNFL can be measured by a non-invasive technique, optical coherence tomography (OCT). Areas covered: This review will cover the history and development of the OCT technology and the advantages of a potential clinical application as a biomarker for axonal loss in MS. Expert opinion: The use of OCT to quantify axonal loss in the RNFL is a promising tool to evaluate disease progression in MS and ON patients. OCT measurements may also correlate with MRI measured brain atrophy and could provide an easily quantified and highly reproducible method in clinical trials to monitor the efficacy of both immune- and neuroprotective therapies. Potential correlations between OCT with other biomarkers that include low contrast vision, visual evoked potentials, color vision and diffusion tensor imaging of the brain and advanced imaging of the optic nerve are promising new frontiers of research.

23 May 2015 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
NCNoel G Carlson
Noel G Carlson
SBSatya Bellamkonda
Satya Bellamkonda
LSLinda Schmidt
Linda Schmidt
JRJonathan Redd
Jonathan Redd
THThomas Huecksteadt
Thomas Huecksteadt
JRJohn W. Rose
John W. Rose
Activity of cyclooxygenase 2 (COX-2) in mouse oligodendrocyte precursor cells (OPCs) modulates vulnerability to excitotoxic challenge. The mechanism by which COX-2 renders OPCs more sensitive to excitotoxicity is not known. In the present study, we examined the hypothesis that OPC excitotoxic death is augmented by COX-2-generated prostaglandin E2 (PGE2) acting on specific prostanoid receptors which could contribute to OPC death. Dispersed OPC cultures prepared from mice brains were examined for expression of PGE2 receptors and the ability to generate PGE2 following activation of glutamate receptors with kainic acid (KA). OPC death in cultures was induced by either KA, 3′-O-(Benzoyl) benzoyl ATP (BzATP) (which stimulates the purinergic receptor P2X7), or TNFα, and the effects of EP3 receptor agonists and antagonists on OPC viability were examined. Stimulation of OPC cultures with KA resulted in nearly a twofold increase in PGE2. OPCs expressed all four PGE receptors (EP1–EP4) as indicated by immunofluorescence and Western blot analyses; however, EP3 was the most abundantly expressed. The EP3 receptor was identified as a candidate contributing to OPC excitotoxic death based on pharmacological evidence. Treatment of OPCs with an EP1/EP3 agonist 17 phenyl-trinor PGE2 reversed protection from a COX-2 inhibitor while inhibition of EP3 receptor protected OPCs from excitotoxicity. Inhibition with an EP1 antagonist had no effect on OPC excitotoxic death. Moreover, inhibition of EP3 was protective against toxic stimulation with KA, BzATP, or TNFα. Therefore, inhibitors of the EP3 receptor appear to enhance survival of OPCs following toxic challenge and may help facilitate remyelination.

1 June 2018 in Seminars in Neurology
Verified
Journal Article
Closed access
PDF file
JWJon P. Williams
Jon P. Williams
JGJohn E. Greenlee
John E. Greenlee
NCNoel G Carlson
Noel G Carlson
Immune-mediated processes represent a rapidly expanding categorical etiology for neurological disease manifestations spanning all subspecialties of neurology. Neural autoantibodies can be grossly divided into two main groups based on localization of the antigen: intracellular and cell membrane/synaptic antibodies. Antibodies reactive with neuronal membrane antigens have been identified in serum and cerebrospinal fluid of patients developing neurological disease either independent of or associated with cancer comorbidity, whereas antibodies directed against intracellular targets have a much higher rate of associated malignancy. Antibodies to neuronal membrane proteins such as the N-methyl-D-aspartate (NMDA) receptor are considered directly pathogenic based on disease models. Similar evidence exists for far fewer autoantibodies directed against intracellular targets. Attempts to produce an antibody-mediated animal model of human paraneoplastic disease have been unsuccessful to date. In this article, we review antineural antibodies and their clinical associations, briefly discuss recently characterized entities, and present proposed mechanisms of antibody pathogenicity.

1 June 2015 in eNeurologicalSci
Verified
Journal Article
Open access
ALAnette S. Loughran-Fjeldstad
Anette S. Loughran-Fjeldstad
NCNoel G Carlson
Noel G Carlson
CHCassandra D. Husebye
Cassandra D. Husebye
LCLarry Cook
Larry Cook
JRJohn W. Rose
John W. Rose
To evaluate quadrant and sector retinal nerve fiber layer (RNFL) thickness and total macular volume (TMV) in relapsing-remitting multiple sclerosis (RR-MS) patients. Optical coherence tomography measures of RNFL and TMV were studied in 321 eyes without prior optic neuritis (ON) (MS unaffected), 151 eyes with prior ON (MS affected), and 148 healthy control eyes. Mean RNFL thickness was significantly lower in the MS affected and MS unaffected groups relative to the control group (p < 0.0001). RNFL thicknesses in the superior, inferior, and temporal quadrants were significantly reduced in MS unaffected (113 ± 15 μm, 119 ± 17 μm, 63 ± 13 μm) (p < 0.001) and MS affected groups (99 ± 19 μm, 103 ± 21 μm, 51 ± 13 μm) (p < 0.0001) compared with that in controls (120 ± 14 μm, 128 ± 15 μm, 69 ± 8 μm, respectively). TMV was significantly reduced in both the MS affected and MS unaffected groups compared with that in the controls (p < 0.0001). Quadrant, sector, and PMB RNFL thicknesses are significant individual measures in RR-MS for both affected and unaffected eyes and may prove valuable in future investigations including biomarker and outcomes research.

1 May 2021 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
SJStephen L. Jaffe
Stephen L. Jaffe
NCNoel G Carlson
Noel G Carlson
LPLisa K. Peterson
Lisa K. Peterson
JGJohn E. Greenlee
John E. Greenlee

12 February 2013 in Neurology
Verified
Journal Article
Closed access
JGJohn Greenlee
John Greenlee
SCSusan Clawson
Susan Clawson
BWBlair Wood
Blair Wood
KHKenneth Hill
Kenneth Hill
ITIkuo Tsunoda
Ikuo Tsunoda
NCNoel G Carlson
Noel G Carlson